These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11403152)

  • 1. The spectrum of vascular disease in dementia. From ischaemia to amyloid angiopathy.
    Weller RO; Preston SD
    Adv Exp Med Biol; 2001; 487():111-22. PubMed ID: 11403152
    [No Abstract]   [Full Text] [Related]  

  • 2. Transgenic mouse models of cerebral amyloid angiopathy.
    Herzig MC; Winkler DT; Walker LC; Jucker M
    Adv Exp Med Biol; 2001; 487():123-8. PubMed ID: 11403153
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models.
    Burgermeister P; Calhoun ME; Winkler DT; Jucker M
    Ann N Y Acad Sci; 2000 Apr; 903():307-16. PubMed ID: 10818520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's dementia by circulation disorders: when trees hide the forest.
    Dotti CG; De Strooper B
    Nat Cell Biol; 2009 Feb; 11(2):114-6. PubMed ID: 19188916
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
    Helman AM; Murphy MP
    Biochim Biophys Acta; 2016 May; 1862(5):975-82. PubMed ID: 26704178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis and common pathology between Alzheimer's disease and vascular dementia].
    Tomimoto H
    Rinsho Shinkeigaku; 2013; 53(11):915-8. PubMed ID: 24291832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E, smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular A beta clearance.
    Prior R; Wihl G; Urmoneit B
    Ann N Y Acad Sci; 2000 Apr; 903():180-6. PubMed ID: 10818506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cerebrovascular actions of amyloid beta-peptides and the protective effect of conjugated estrogens.
    Rhodin JA; Thomas TN; Clark L; Garces A; Bryant M
    J Alzheimers Dis; 2003 Aug; 5(4):275-86. PubMed ID: 14624023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical phenotypes of Cerebral Amyloid Angiopathy.
    Maia LF; Mackenzie IR; Feldman HH
    J Neurol Sci; 2007 Jun; 257(1-2):23-30. PubMed ID: 17341423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.
    Weller RO; Massey A; Kuo YM; Roher AE
    Ann N Y Acad Sci; 2000 Apr; 903():110-7. PubMed ID: 10818495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.
    Weller RO; Nicoll JA
    Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells.
    Ravi LB; Mohanty JG; Chrest FJ; Jayakumar R; Nagababu E; Usatyuk PV; Natarajan V; Rifkind JM
    Neurol Res; 2004 Jul; 26(5):579-85. PubMed ID: 15265278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.
    Thal DR; Ghebremedhin E; Orantes M; Wiestler OD
    J Neuropathol Exp Neurol; 2003 Dec; 62(12):1287-301. PubMed ID: 14692704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid, blood vessels, and brain function.
    Smith EE; Greenberg SM
    Stroke; 2009 Jul; 40(7):2601-6. PubMed ID: 19443808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
    Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
    Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly.
    Zekry D; Duyckaerts C; Moulias R; Belmin J; Geoffre C; Herrmann F; Hauw JJ
    Acta Neuropathol; 2002 May; 103(5):481-7. PubMed ID: 11935264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia.
    Haglund M; Sjöbeck M; Englund E
    Dement Geriatr Cogn Disord; 2004; 18(2):132-7. PubMed ID: 15211067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
    Román GC; Kalaria RN
    Neurobiol Aging; 2006 Dec; 27(12):1769-85. PubMed ID: 16300856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease.
    Vidoni ED; Yeh HW; Morris JK; Newell KL; Alqahtani A; Burns NC; Burns JM; Billinger SA
    Neurodegener Dis; 2016; 16(3-4):218-24. PubMed ID: 26756746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.